1. Home
  2. QURE vs DCBO Comparison

QURE vs DCBO Comparison

Compare QURE & DCBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • DCBO
  • Stock Information
  • Founded
  • QURE 1998
  • DCBO 2016
  • Country
  • QURE Netherlands
  • DCBO Canada
  • Employees
  • QURE N/A
  • DCBO N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • DCBO
  • Sector
  • QURE Health Care
  • DCBO
  • Exchange
  • QURE Nasdaq
  • DCBO Nasdaq
  • Market Cap
  • QURE 866.3M
  • DCBO 893.7M
  • IPO Year
  • QURE 2007
  • DCBO 2020
  • Fundamental
  • Price
  • QURE $17.10
  • DCBO $30.20
  • Analyst Decision
  • QURE Strong Buy
  • DCBO Strong Buy
  • Analyst Count
  • QURE 11
  • DCBO 5
  • Target Price
  • QURE $39.91
  • DCBO $42.20
  • AVG Volume (30 Days)
  • QURE 966.4K
  • DCBO 95.2K
  • Earning Date
  • QURE 11-04-2025
  • DCBO 11-07-2025
  • Dividend Yield
  • QURE N/A
  • DCBO N/A
  • EPS Growth
  • QURE N/A
  • DCBO 33.51
  • EPS
  • QURE N/A
  • DCBO 0.69
  • Revenue
  • QURE $14,337,000.00
  • DCBO $230,502,000.00
  • Revenue This Year
  • QURE N/A
  • DCBO $13.02
  • Revenue Next Year
  • QURE $301.10
  • DCBO $8.37
  • P/E Ratio
  • QURE N/A
  • DCBO $43.77
  • Revenue Growth
  • QURE N/A
  • DCBO 15.11
  • 52 Week Low
  • QURE $4.45
  • DCBO $25.50
  • 52 Week High
  • QURE $19.18
  • DCBO $53.86
  • Technical
  • Relative Strength Index (RSI)
  • QURE 60.57
  • DCBO 45.86
  • Support Level
  • QURE $16.69
  • DCBO $30.10
  • Resistance Level
  • QURE $17.76
  • DCBO $31.96
  • Average True Range (ATR)
  • QURE 0.77
  • DCBO 0.83
  • MACD
  • QURE 0.01
  • DCBO -0.13
  • Stochastic Oscillator
  • QURE 62.76
  • DCBO 14.15

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

Share on Social Networks: